Abstract
Goals
To examine the prevalence of chemotherapy-or radiotherapy-associated side effects and related treatment burden, and correlates of fatigue and missed work days among cancer patients.
Materials and methods
A cross-sectional survey was conducted using a dual sampling frame of 63,949 cancer patients (35,751 from an online panel and 28,198 from telephone listings) ≥18 years receiving chemotherapy and/or radiotherapy at the time of the survey or during the previous 12 months. Data were collected on cancer type, time since diagnosis, treatment side effects, visits, caregiver burden, missed work days, and sociodemographic characteristics. Data are presented only for patients receiving cancer treatment at the time of the survey.
Main results
Of the 15,532 patients (24%) who responded to the screening questionnaire, 1,572 met the eligibility criteria and 1,569 completed the survey; 814 received chemotherapy and/or radiotherapy at the time of the survey. The most common side effects were fatigue (80%), pain (48%), and nausea/vomiting (48%). Patients spent 4.5 h, on average, per visit to treat side effects. Approximately 43% of the patients were employed; of these, 78% were actively working. Employed patients missed, on average, 18 work days annually for side effect treatment. Females, younger and unemployed patients, and those with higher levels of anxiety and depression experienced more fatigue; patients with a greater number of side effects endured more missed work days.
Conclusions
In addition to the symptomatic experience of side effects, patients reported a considerable time burden for treatment. It is important to consider supportive care strategies that may effectively reduce side effects and their associated treatment burden.
Similar content being viewed by others
References
Anderson KO, Giralt SA, Mendoza TR, Brown JO, Neumann JL, Mobley GM, Wang XS, Cleeland CS (2007) Symptom burden in patients undergoing autologous stem-cell transplantation. Bone Marrow Transplant 39:759–766
Andritsch E, Dietmaier G, Hofmann G, Zloklikovits S, Samonigg H (2007) Global quality of life and its potential predictors in breast cancer patients: an exploratory study. Support Care Cancer 15:21–30
Andrykowski MA, Schmidt JE, Salsman JM, Beacham AO, Jacobsen PB (2005) Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol 23:6613–6622
Basch E, Iasonos A, McDonough T, Barz A, Culkin A, Kris MG, Scher HI, Schrag D (2006) Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol 7:903–909
Bennett B, Goldstein D, Lloyd A, Davenport T, Hickie I (2004) Fatigue and psychological distress—exploring the relationship in women treated for breast cancer. Eur J Cancer 40:1689–1695
Berndt E, Kallich J, McDermott A, Xu X, Lee H, Glaspy J (2005) Reductions in anaemia and fatigue are associated with improvements in productivity in cancer patients receiving chemotherapy. PharmacoEconomics 23:505–514
Bradley CJ, Bednarek HL (2002) Employment patterns of long-term cancer survivors. Psycho-oncology 11:188–198
Bradley CJ, Oberst K, Schenk M (2006) Absenteeism from work: the experience of employed breast and prostate cancer patients in the months following diagnosis. Psycho-oncology 15:739–747
Butt Z, Wagner LI, Beaumont JL, Paice JA, Straus JL, Peterman AH, Carro G, Von Roenn JH, Shevrin D, Cella D (2007) Longitudinal screening and management of fatigue, pain, and emotional distress associated with cancer therapy. Support Care Cancer (in press)
Carlson LE, Angen M, Cullum J, Goodey E, Koopmans J, Lamont L, MacRae JH, Martin M, Pelletier G, Robinson J, Simpson JS, Speca M, Tillotson L, Bultz BD (2004) High levels of untreated distress and fatigue in cancer patients. Br J Cancer 90:2297–2304
Cella D (2002) The effects of anemia and anemia treatment on the quality of life of people with cancer. Oncology 16:125–132
Cella D, Eton DT, Lai JS, Peterman AH, Merkel DE (2002) Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage 24:547–561
Cella D, Kallich J, McDermott A, Xu X (2004) The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials. Ann Oncol 15:979–986
Cella D, Lai JS, Chang CH, Peterman A, Slavin M (2002) Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94:528–538
Cella D, Peterman A, Passik S, Jacobsen P, Breitbart W (1998) Progress toward guidelines for the management of fatigue. Oncology (Willist Park N Y) 12:369–377
Cohen J (1988) Statistical power analysis for the behavioral sciences. Erlbaum, Hillsdale, NJ
Curt GA (2000) The impact of fatigue on patients with cancer: overview of FATIGUE 1 and 2. Oncologist 5(Suppl 2):9–12
Curt GA (2000) Impact of fatigue on quality of life in oncology patients. Semin Hematol 37:14–17
Curt GA, Breitbart W, Cella D, Groopman JE, Horning SJ, Itri LM, Johnson DH, Miaskowski C, Scherr SL, Portenoy RK, Vogelzang NJ (2000) Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5:353–360
Derogatis LR (1993) Brief symptom inventory administration, scoring, and procedures manual. NCS Pearson, Minneapolis
Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, Henrichs M, Carnicke CL Jr (1983) The prevalence of psychiatric disorders among cancer patients. JAMA 249:751–757
Dillon E, Kelly J (2003) The status of cancer fatigue on the Island of Ireland: AIFC professional and interim patient surveys. Oncologist 8(Suppl 1):22–26
Fossa SD, Dahl AA, Loge JH (2003) Fatigue, anxiety, and depression in long-term survivors of testicular cancer. J Clin Oncol 21:1249–1254
Gabrilove JL, Perez EA, Tomita DK, Rossi G, Cleeland CS (2007) Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks. Cancer 110:1629–1640
Gapstur RL (2007) Symptom burden: a concept analysis and implications for oncology nurses. Oncol Nurs Forum 34:673–680
Griffin AM, Butow PN, Coates AS, Childs AM, Ellis PM, Dunn SM, Tattersall MH (1996) On the receiving end. V: patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 7:189–195
Groopman JE, Itri LM (1999) Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst 91:1616–1634
Haley WE (2003) Family caregivers of elderly patients with cancer: understanding and minimizing the burden of care. J Support Oncol 1:25–29
Houts AC, Loh GA, Fortner BV, Kallich JD (2006) Patient and caregiver time burden associated with anaemia treatment in different patient populations. Support Care Cancer 14:1195–1204
Hwang SS, Chang VT, Kasimis BS (2003) A comparison of three fatigue measures in veterans with cancer. Cancer Investig 21:363–373
Kallich JD, Tchekmedyian NS, Damiano AM, Shi J, Black JT, Erder MH (2002) Psychological outcomes associated with anemia-related fatigue in cancer patients. Oncology (Willist Park N Y) 16:117–124
Kessler RC, Greenberg PE, Mickelson KD, Meneades LM, Wang PS (2001) The effects of chronic medical conditions on work loss and work cutback. J Occup Environ Med 43:218–225
Khalid U, Spiro A, Baldwin C, Sharma B, McGough C, Norman AR, Eisen T, O’Brien ME, Cunningham D, Andreyev HJ (2007) Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer 15:39–46
Maliski SL, Kwan L, Orecklin JR, Saigal CS, Litwin MS (2005) Predictors of fatigue after treatment for prostate cancer. Urology 65:101–108
Meehan KR, Tchekmedyian NS, Smith RE, Kallich J (2006) Resource utilisation and time commitment associated with correction of anaemia in cancer patients using epoetin alfa. Clin Drug Investig 26:593–601
Mock V (2007) NCCN Guidelines (NCCN practice guidelines in oncology—cancer-related fatigue). Version 2.2007. NCCN Clinical Practice Guidelines in Oncology
Morrow GR, Shelke AR, Roscoe JA, Hickok JT, Mustian K (2005) Management of cancer-related fatigue. Cancer Investig 23:229–239
National Center for Health Statistics (2007) 2005 NHIS questionnaire—sample adult. In: 2005 NHIS questionnaire. Available at ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Survey_Questionnaires/NHIS/2005/English/
Patrick DL, Gagnon DD, Zagari MJ, Mathijs R, Sweetenham J, Epoetin Alfa Study G (2003) Assessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfa. Eur J Cancer 39:335–345
Prieto JM, Blanch J, Atala J, Carreras E, Rovira M, Cirera E, Gasto C (2006) Clinical factors associated with fatigue in haematologic cancer patients receiving stem-cell transplantation. Eur J Cancer 42:1749–1755
Redeker NS, Lev EL, Ruggiero J (2000) Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Sch Inq Nurs Pract 14:275–290
Skarstein J, Aass N, Fossa SD, Skovlund E, Dahl AA (2000) Anxiety and depression in cancer patients: relation between the hospital anxiety and depression scale and the European organization for research and treatment of cancer core quality of life questionnaire. J Psychosom Res 49:27–34
Stefanek ME, Derogatis LP, Shaw A (1987) Psychological distress among oncology outpatients. Prevalence and severity as measured with the brief symptom inventory. Psychosomatics 28:530–532
Stone P, Richardson A, Ream E, Smith AG, Kerr DJ, Kearney N (2000) Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer fatigue forum. Ann Oncol 11:971–975
Taskila-Abrandt T, Pukkala E, Martikainen R, Karjalainen A, Hietanen P (2005) Employment status of Finnish cancer patients in 1997. Psycho-oncology 14:221–226
Tauer K, Zhu L, Fortner B (2004) The impact of anemia treatment visits on the patient and their caregiver. Proc Am Soc Clin Oncol 23:753 (Abstract 8114)
Tchekmedyian NS, Kallich J, McDermott A, Fayers P, Erder MH (2003) The relationship between psychologic distress and cancer-related fatigue. Cancer 98:198–203
Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A (2007) Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage 34:94–104
Tran KT, Stephens MK et al (2006) Impact of chemotherapy-induced anemia on economic and quality of life outcomes in adults with cancer. Blood 108:Abstract 3355
Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ, Itri LM, Johnson DH, Scherr SL, Portenoy RK, Coalition TF (1997) Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. Semin Hematol 34:4–12
Yabroff KR, Lawrence WF, Clauser S, Davis WW, Brown ML (2004) Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst 96:1322–1330
Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S, Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S (2001) The prevalence of psychological distress by cancer site. Psycho-oncology 10:19–28
Acknowledgements
We acknowledge Joel D. Kallich Ph.D. at Amgen Inc. for his contribution in designing the study. We thank Niall Harrison at Gardiner-Caldwell London and Geoffrey Smith at Amgen Inc. for the editorial assistance. This study was sponsored by a grant from Amgen Inc.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Henry, D.H., Viswanathan, H.N., Elkin, E.P. et al. Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S.. Support Care Cancer 16, 791–801 (2008). https://doi.org/10.1007/s00520-007-0380-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-007-0380-2